| Detected | Trial | Change |
|---|---|---|
| 2026-05-28 | NCT06973187 A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in… |
Trial sites expanded: 149 -> 154 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06970743 | A Study of BGB-16673 Compared to Investigator's Choice in Participants With… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06846671 | A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic… | CLL | Recruiting |
| NCT06973187 | A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in… | Chronic Lymphocytic Leukemia | Recruiting |
| Phase 2 | |||
| NCT07508995 | A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With… | Chronic Lymphocytic Leukemia (CLL) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05294731 | Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton… | B-cell Malignancy | Recruiting |
| NCT05006716 | A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell… | B-cell Malignancy | Recruiting |
| NCT06634589 | A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other… | B-cell Malignancy | Recruiting |
| Phase 1 | |||
| NCT07005713 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… | Chronic Spontaneous Urticaria | Active, Not Recruiting |